SCHEMBL23474256

SCHEMBL23474256

Cc1cc(N)cc(S(=O)(=O)NCc2ccccc2Cl)c1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.55
ALDH1A1 P00352 2/20 0.55
HPGD P15428 1/20 0.55
MAPK1 P28482 1/20 0.55
HTT P42858 1/20 0.52
KMT2A Q03164 4/20 0.49
MEN1 O00255 2/20 0.49
HTR2C P28335 1/20 0.49
HTR2B P41595 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
LMNA P02545 2/20 0.48
MAPT P10636 2/20 0.47
TP53 P04637 2/20 0.47
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
GAA P10253 1/20 0.44
TSHR P16473 1/20 0.44
CYP2C19 P33261 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6094935 0.85 POLB (0.53) POLBALDH1A1HPGDMAPK1HTT
SCHEMBL6092274 0.85 POLB (0.53) POLBALDH1A1HPGDMAPK1HTT
SCHEMBL6092279 0.84 POLB (0.52) POLBALDH1A1HPGDMAPK1HTT
SCHEMBL6094939 0.84 POLB (0.52) POLBALDH1A1HPGDMAPK1HTT
SCHEMBL23511448 0.84 POLB (0.52) POLBALDH1A1HPGDMAPK1HTT
SCHEMBL28113175 0.80 POLB (0.68) POLBALDH1A1HPGDMAPK1HTT
SCHEMBL5960083 0.80 KMT2A (0.72) POLBALDH1A1HPGDMAPK1KMT2A
SCHEMBL5848695 0.79 POLB (0.52) POLBALDH1A1HPGDMAPK1HTT
SCHEMBL5960067 0.78 SMN1; SMN2 (0.54) POLBALDH1A1HPGDMAPK1HTT
SCHEMBL4662993 0.77 POLB (0.70) POLBALDH1A1HPGDMAPK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021178902-A1 METHODS OF INHIBITING MASP-2 FOR THE TREATMENT AND/OR PREVENTION OF CORONAVIRUS-INDUCED ACUTE RESPIRATORY DISTRESS SYNDROME OMEROS CORPORATION (US) 2021-09-10 WO disclosed
WO-2021113686-A1 MASP-2 INHIBITORS AND METHODS OF USE OMEROS CORPORATION (US) 2021-06-10 WO disclosed